Accessibility Menu
 
Organon & Co. logo

Organon & Co.

(NYSE) OGN

Current Price$13.32
Market Cap$3.48B
Since IPO (2021)-51%
5 YearN/A
1 Year+40%
1 Month+108%

Organon & Co. Financials at a Glance

Market Cap

$3.48B

Revenue (TTM)

$6.16B

Net Income (TTM)

$246.00M

EPS (TTM)

$0.93

P/E Ratio

14.21

Dividend

$0.08

Beta (Volatility)

0.91 (Low)

Price

$13.32

Volume

281,779

Open

$13.29

Previous Close

$13.32

Daily Range

$13.27 - $13.34

52-Week Range

$5.69 - $13.39

About Organon & Co.

Industry

Pharmaceuticals

Employees

10,000

CEO

Joseph T. Morrissey, Jr., MBA

Headquarters

Jersey City, NJ 07302, US

OGN Financials

Key Financial Metrics (TTM)

Gross Margin

53%

Operating Margin

19%

Net Income Margin

4%

Return on Equity

31%

Return on Capital

113%

Return on Assets

19%

Earnings Yield

7.04%

Dividend Yield

0.60%

Payout Ratio

6.91%

Stock Overview

Market Cap

$3.48B

Shares Outstanding

262.60M

Volume

281.78K

Avg. Volume

8.92M

Financials (TTM)

Gross Profit

$3.36B

Operating Income

$1.28B

EBITDA

$1.28B

Operating Cash Flow

$700.00M

Capital Expenditure

$162.00M

Free Cash Flow

$538.00M

Cash & ST Invst.

$574.00M

Total Debt

$8.80B

Organon & Co. Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$1.46B

-3.5%

Gross Profit

$783.00M

-6.9%

Gross Margin

53.63%

N/A

Market Cap

$3.48B

N/A

Market Cap/Employee

$348.21K

N/A

Employees

10,000

N/A

Net Income

$146.00M

+67.8%

EBITDA

$351.00M

+8.0%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$7.45M

+99.9%

Accounts Receivable

$1.38M

-99.9%

Inventory

$1.37M

-99.9%

Long Term Debt

$8.55M

-99.9%

Short Term Debt

$16.00K

-99.9%

Return on Assets

18.93%

N/A

Return on Invested Capital

112.90%

N/A

Free Cash Flow

$0.00

+100.0%

Operating Cash Flow

$0.00

-100.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GRDNGuardian Pharmacy Services, Inc.
$37.24+1.64%
PAHCPhibro Animal Health Corporation
$56.24+2.85%
AUPHAurinia Pharmaceuticals Inc.
$16.04+1.71%
AVDLAvadel Pharmaceuticals plc
$21.64+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
DGXXDigi Power X
$5.11+0.29%
NOKNokia
$13.42+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.96-0.02%
CCLCarnival Corp.
$25.77+0.00%

Questions About OGN

What is the current price of Organon & Co.?

Organon & Co. is trading at $13.33 per share.

What is the 52-week range for Organon & Co.?

Over the past 52 weeks, Organon & Co. has traded between $5.69 and $13.39.

How much debt does Organon & Co. have?

As of the most recent reporting period, Organon & Co. reported total debt of $8.57B.

How much cash does Organon & Co. have on hand?

Organon & Co. reported $1.12B in cash and cash equivalents in its most recent financial results.

What is Organon & Co.’s dividend yield?

Organon & Co. currently has a dividend yield of 0.60%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.